Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Dana-Farber Cancer Institute
Fondazione Italiana Linfomi - ETS
University of Nebraska
University of Nebraska
Universität des Saarlandes
Royal Marsden NHS Foundation Trust
Ruijin Hospital
University of Miami
Samsung Medical Center
M.D. Anderson Cancer Center